Elanco Animal Health (ELAN) EBIAT (2017 - 2025)
Elanco Animal Health (ELAN) has disclosed EBIAT for 9 consecutive years, with -$276.0 million as the latest value for Q4 2025.
- Quarterly EBIAT fell 3350.0% to -$276.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$232.0 million through Dec 2025, down 168.64% year-over-year, with the annual reading at -$232.0 million for FY2025, 168.64% down from the prior year.
- EBIAT hit -$276.0 million in Q4 2025 for Elanco Animal Health, down from -$34.0 million in the prior quarter.
- In the past five years, EBIAT ranged from a high of $364.0 million in Q3 2024 to a low of -$1.1 billion in Q3 2023.
- Historically, EBIAT has averaged -$84.3 million across 5 years, with a median of -$52.0 million in 2022.
- Biggest five-year swings in EBIAT: skyrocketed 179.69% in 2022 and later crashed 3350.0% in 2025.
- Year by year, EBIAT stood at -$105.0 million in 2021, then surged by 48.57% to -$54.0 million in 2022, then tumbled by 161.11% to -$141.0 million in 2023, then soared by 94.33% to -$8.0 million in 2024, then plummeted by 3350.0% to -$276.0 million in 2025.
- Business Quant data shows EBIAT for ELAN at -$276.0 million in Q4 2025, -$34.0 million in Q3 2025, and $11.0 million in Q2 2025.